14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -0.810 2 days ( 0.95 % )
Last Price $4.15 -0.95 %
High/ Low $4.10 - $4.26 9.27%
Chg 7 Days 6.68 % $3.89 $4.15
Chg 30 Days -13.72 % $4.81 $4.15
Chg 12 mos -45.61 % $7.63 $4.15
Trend - 3 mos 2.82 % Width: 56.99 %
Trend - 12 mos -46.97 % Width: 92.80 %
Pred. range - 3 mos $4.01 - $6.30 -3.29 % - 51.83 %
Pred. range - 12 mos $1.45 - $2.80 -65.04 % - -32.59 %
Short MA avg 3 mos Buy Apr 19, 2024 - 4 days
Long MA avg 3 mos Buy Mar 22, 2024 - 23 days
Short/Long MA avg 3 mos Sell Mar 26, 2024 - 21 days
Short MA avg 12 mos Sell Mar 18, 2024 - 27 days
Long MA avg 12 mos Buy Mar 12, 2024 - 31 days
Short/Long MA avg 12 mos Sell Apr 04, 2024 - 15 days
Pivot Short Sell Apr 17, 2024 - 6 days
Bollinger Buy Feb 22, 2024 - 44 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT